Literature DB >> 21822800

Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.

Michael F Wangler1, Lawrence T Reiter, Georgianna Zimm, Jennifer Trimble-Morgan, Jane Wu, Ethan Bier.   

Abstract

Alzheimer's disease (AD) pathogenesis is characterized by senile plaques in the brain and evidence of oxidative damage. Oxidative stress may precede plaque formation in AD; however, the link between oxidative damage and plaque formation remains unknown. Presenilins are transmembrane proteins in which mutations lead to accelerated plaque formation and early-onset familial Alzheimer's disease. Presenilins physically interact with two antioxidant enzymes thiol-specific antioxidant (TSA) and proliferation-associated gene (PAG) of the peroxiredoxin family. The functional consequences of these interactions are unclear. In the current study we expressed a presenilin transgene in Drosophila wing and sensory organ precursors of the fly. This caused phenotypes typical of Notch signaling loss-of-function mutations. We found that while expression of TSA or PAG alone produced no phenotype, co-expression of TSA and PAG with presenilin led to an enhanced Notch loss-of-function phenotype. This phenotype was more severe and more penetrant than that caused by the expression of Psn alone. In order to determine whether these phenotypes were indeed affecting Notch signaling, this experiment was performed in a genetic background carrying an activated Notch (Abruptex) allele. The phenotypes were almost completely rescued by this activated Notch allele. These results link peroxiredoxins with the in vivo function of Presenilin, which ultimately connects two key pathogenetic mechanisms in AD, namely, antioxidant activity and plaque formation, and raises the possibility of a role for peroxiredoxin family members in Alzheimer's pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822800      PMCID: PMC3702159          DOI: 10.1007/s13238-011-1073-7

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  53 in total

1.  Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.

Authors:  S Leutner; C Czech; K Schindowski; N Touchet; A Eckert; W E Müller
Journal:  Neurosci Lett       Date:  2000-10-06       Impact factor: 3.046

Review 2.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 3.  The presenilins in Alzheimer's disease--proteolysis holds the key.

Authors:  C Haass; B De Strooper
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

4.  Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.

Authors:  N D Mehta; L M Refolo; C Eckman; S Sanders; D Yager; J Perez-Tur; S Younkin; K Duff; J Hardy; M Hutton
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

5.  A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Authors:  B De Strooper; W Annaert; P Cupers; P Saftig; K Craessaerts; J S Mumm; E H Schroeter; V Schrijvers; M S Wolfe; W J Ray; A Goate; R Kopan
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

Review 6.  Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.

Authors:  M A Smith; A Nunomura; X Zhu; A Takeda; G Perry
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

7.  Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin.

Authors:  P Nowotny; S M Gorski; S W Han; K Philips; W J Ray; V Nowotny; C J Jones; R F Clark; R L Cagan; A M Goate
Journal:  Mol Cell Neurosci       Date:  2000-01       Impact factor: 4.314

8.  Differential alterations in antioxidant capacity in cells from Alzheimer patients.

Authors:  G E Gibson; H Zhang; K R Sheu; L C Park
Journal:  Biochim Biophys Acta       Date:  2000-11-15

Review 9.  Binding partners of Alzheimer's disease proteins: are they physiologically relevant?

Authors:  G Van Gassen; W Annaert; C Van Broeckhoven
Journal:  Neurobiol Dis       Date:  2000-06       Impact factor: 5.996

10.  Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain.

Authors:  F Oyama; N Sawamura; K Kobayashi; M Morishima-Kawashima; T Kuramochi; M Ito; T Tomita; K Maruyama; T C Saido; T Iwatsubo; A Capell; J Walter; J Grünberg; Y Ueyama; C Haass; Y Ihara
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

View more
  1 in total

Review 1.  Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.

Authors:  R Scott Duncan; Bob Song; Peter Koulen
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.